Citations

Clear

35 citation(s) found for "Smits, P".

Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity
Laali, Kenneth K. , Greves, William J., Zwarycz, Angela T. , Smits, Sebastian J. Correa, Troendle, Frederick J., Borosky, Gabriela L. , Manna, Alak , Paulus, Aneel , Chanan‐Khan, Asher , Nukaya, Manabu , Kennedy, Gregory D. , Akhtar, Sharoon , Chanan-Khan, Asher, Paulus, Aneel

Mayo Clinic

ChemMedChem | August 7, 2018 | Volume: 13 | Issue: 18 | Pages: 1895-1908

10.1002/cmdc.201800320 | PMID 30079563 Get It

AbstractIn a continuing search for curcuminoid (CUR) compounds with antitumor activity, a novel series of heterocyclic CUR–BF2 adducts and CUR compounds based on indole, benzothiophene, and benzofuran along with their aryl pyrazoles were synthesized. Computational docking studies were performed to compare binding efficiency to target proteins involved in specific cancers, namely HER2, proteasome, VEGFR, BRAF, and Bcl‐2, versus known inhibitor drugs. The majority presented very good binding affinities, similar to, and even more favorable than those of known inhibitors. The indole‐based CUR–BF2 and CUR compounds and their bis‐thiocyanato derivatives exhibited high anti‐proliferative and apoptotic activity by in vitro bioassays against a panel of 60 cancer cell lines, more specifically against multiple myeloma (MM) cell lines (KMS11, MM1.S, and RPMI‐8226) with significantly lower IC50 values versus healthy PBMC cells; they also exhibited higher anti‐proliferative activity in human colorectal cancer cells (HCT116, HT29, DLD‐1, RKO, SW837, and Caco2) than the parent curcumin, while showing notably lower cytotoxicity in normal colon cells (CCD112CoN and CCD841CoN).
Individualized Responses of Gut Microbiota to Dietary Intervention Modeled in Humanized Mice
Smits, Samuel A. , Marcobal, Ángela, Sonnenburg, Justin L. , Kashyap, Purna , Higginbottom, Steven K.

Mayo Clinic

mSystems | September 7, 2016 | Volume: 1 | Issue: 5 | Pages: No page available

10.1128/msystems.00098-16 | PMID 27822551 Get It

Dietary modification has long been used empirically to modify symptoms in inflammatory bowel disease, irritable bowel syndrome, and a diverse group of diseases with gastrointestinal symptoms. There is both anecdotal and scientific evidence to suggest that individuals respond quite differently to similar dietary changes, and the highly individualized nature of the gut microbiota makes it a prime candidate for these differences. To overcome the typical confounding factors of human dietary interventions, here we employ ex-germfree mice colonized by microbiotas of three different humans to test how different microbiotas respond to a defined change in carbohydrate content of diet by measuring changes in microbiota composition and function using marker gene-based next-generation sequencing and metabolomics. Our findings suggest that the same diet has very different effects on each microbiota’s membership and function, which may in turn explain interindividual differences in response to a dietary ingredient.
Surgical morbidity and clinical outcomes in ovarian cancer – the role of obesity
Smits, Anke , Das, N, Cliby, William A. , Smits, Eline, Bekkers, Ruud L.M. , Massuger, L.F.A.G., Galaal, Khadra , Lopes, Alberto , Kumar, Amanika

Mayo Clinic

BJOG: An International Journal of Obstetrics & Gynaecology | August 26, 2015 | Volume: 123 | Issue: 2 | Pages: 300-308

10.1111/1471-0528.13585 | PMID 26331299 Get It

ObjectiveTo evaluate the effect of body mass index on the surgical outcomes in ovarian cancer patients. In addition, we performed a systematic review to compare our outcomes with the current literature.DesignRetrospective cohort study and a systematic review of the literature.SettingGynaecology department at the Royal Cornwall Hospital Trust.PopulationSurgically managed stage I‐IV ovarian cancer patients between September 2006 and September 2014.MethodsPrimary and secondary outcome measures were evaluated across BMI categories; BMI <25 kg/m², BMI 25–29.9 kg/m², BMI ≥30 kg/m² and BMI ≥40 kg/m². A systematic review was performed according to Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) guidelines.Main outcome measuresThe primary outcome measure was surgical complications. Secondary outcome measures were other intra‐ and postoperative outcomes.ResultsTwo hundred twenty‐eight women were included in the study, of which 84 had a BMI <25 kg/m², 84 women had a BMI 25–29.9 kg/m², and 60 women were obese (BMI ≥30 kg/m²), 13 of whom were morbidly obese. Morbid obesity was associated with increased rates of wound complications. However, BMI did not show an association with other outcomes. In the review, an increasing BMI was associated with increased rates of wound complications and prolonged hospital stay, but did not impact other surgical outcomes.ConclusionObesity is associated with increased rates of wound complications and a prolonged hospital stay, but does not appear to affect other operative outcomes including cytoreduction status and 30‐day mortality. Therefore, operative management and postoperative care require a multifactorial approach to minimise adverse outcomes.Tweetable abstractObesity is associated with more wound complications and prolonged hospital stay in ovarian cancer surgery.
Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota
Kashyap, Purna , Marcobal, Ángela, Ursell, Luke K., Smits, Samuel A. , Sonnenburg, Erica D. , Costello, Elizabeth K. , Higginbottom, Steven K. , Domino, Steven E. , Holmes, Susan , Relman, David A. , Knight, Rob , Gordon, Jeffrey I. , Sonnenburg, Justin L.

Mayo Clinic

Proceedings of the National Academy of Sciences | September 24, 2013 | Volume: 110 | Issue: 42 | Pages: 17059-17064

10.1073/pnas.1306070110 | PMID 24062455 Get It

Significance Our data demonstrate that differences in host genotype that affect the carbohydrate landscape of the distal gut interact with diet to alter the composition and function of resident microbes in a diet-dependent manner.
C-Type Natriuretic Peptide–Induced Vasodilation Is Dependent On Hyperpolarization in Human Forearm Resistance Vessels
宮浦, 一成, Smits, P, Morrison, P J, Burnett, J C, Rabelink, T J, Rabelink, Ton J. , Smits, P, Morrison, P J, Burnett, J C, Rabelink, T J

Mayo Clinic

Hypertension | June 12, 2012 | Volume: 37 | Issue: 4 | Pages: 1179-1183

10.1161/01.hyp.37.4.1179 | PMID 11304521 Get It

Abstract—Animal studies have demonstrated that CNP causes endothelium-independent vasodilation, which is limited by neutral endopeptidase (NEP) activity. However, the vasodilating mechanism of CNP in humans is still unknown. Therefore, we investigated the vasodilator actions of CNP in human forearm resistance vessels before and after inhibition of nitric oxide (NO) and then prostacyclin production and after inhibition of Ca2+-dependent potassium channel activation and NEP activity. Three separate studies were performed. In each study, forearm blood flow was recorded by venous occlusion plethysmography in 8 healthy nonsmoking subjects. Brachial artery infusion of CNP (70, 140, 280, and 560 ng per 100 mL forearm volume per minute) caused significant forearm vasodilation in all studies (forearm blood flow from 3.94 to 8.50 mL per 100 mL forearm volume per minute). Inhibition of the endogenous generation of NO byl-NG-monomethyl arginine (by use of the NO-clamp technique) did not block the maximal vasodilating effects of CNP (forearm blood flow from 3.69 to 6.93). In addition, when the cyclooxygenase system was inhibited by 600 mg of acetylsalicylic acid (aspirin) administered orally 30 minutes before start of measurements, the rise in forearm blood flow remained intact (forearm blood flow from 3.31 to 8.27 mL per 100 mL forearm volume per minute). However, inhibition of Ca2+-dependent potassium channels with tetraethylammonium chloride (0.1 mg per 100 mL forearm volume per minute) significantly attenuated vasodilation caused by CNP (forearm blood flow from 2.28 to 3.06 mL per 100 mL forearm volume per minute), which suggests that CNP opens vascular potassium channels. Vasodilation to all doses of CNP was significantly increased when activity of NEP was blocked with thiorphan (30 nmol/min), which suggests that NEP activity limits vasodilation of CNP. CNP is a dilator of human resistance vessels that mediates its effects through hyperpolarization of the vessel wall independent of the NO and prostaglandin system. Inhibition of local NEP activity increases CNP bioavailability. This may be of relevance to cardiovascular disease, given that vascular tone is well balanced between NO and an endothelium-derived hyperpolarizing factor, which suggests that in pathological situations, impaired NO activity can be compensated for by enhanced endothelium-derived hyperpolarizing factor release to maintain vascular homeostasis.